Showing results (711-720 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|March 3, 2018
A cost-utility analysis of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health ServiceShyam Ajay Gokani, Karl O Elmqvist, Osman El-Koubani, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 31, 2014
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic reviewChristos Chouaïd, Perinne Crequit, Isabelle Borget, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 19, 2013
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States Medicare population: potential economic implications of a new minimally-invasive technologyStacey J Ackerman, David W Polly, Tyler Knight, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 16, 2017
Severe forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient careTobias Romeyke, Elisabeth Noehammer, Hans Christoph Scheuer, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 17, 2018
Claims-based proxies of patient instability among commercially insured adults with schizophreniaCharles Ruetsch, Hyong Un, Heidi C Waters
Clinicoeconomics and Outcomes Research : CEOR|July 10, 2018
Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trialPeter Douglas Klassen, Wellington K Hsu, Frederic Martens, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 15, 2018
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilarLee S Schwartzberg, Lincy S Lal, Sanjeev Balu, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 14, 2018
The burden of cystic fibrosis in the Medicaid populationMariam Hassan, Machaon M Bonafede, Brendan L Limone, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2016
A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regionsJosep Darbà, Gabriela Ramírez, Juan L García-Rivero, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 12, 2017
Healthcare resource consumption and cost of care among patients with polycystic kidney disease in ItalyLuca Degli Esposti, Chiara Veronesi, Valentina Perrone, et al.
Pageof 102